Even as deal activity remains slower, M&A work for biotech and healthcare companies is providing a significant lift for some large law firms now, with the latest examples including three multi-billion deals announced in the last week.

About a dozen law firms landed on those deals, which included Merck agreeing to acquire Prometheus Biosciences Inc.; TPG Capital and AmerisourceBergen going forward with a purchase of OneOncology; and GlaxoSmithKline agreeing to acquire BELLUS Health Inc.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]